Defendant Name: Sequenom, Inc.

Defendant Type: Public Company
SIC Code: 8731
CUSIP: 81733740

Initial Case Details

Legal Case Name In the Matter of Sequenom, Inc.
First Document Date 01-Sep-2011
Initial Filing Format Administrative Action
File Number 3-14524
Allegation Type Issuer Reporting and Disclosure

Violations Alleged

Exchange Act
Sec 10(b) + Rule 10b-5
Rule 12b-20
Sec 13(a)
Rule 13a-1
Rule 13a-11


First Resolution Date 01-Sep-2011

Related Documents:

34-65247 01-Sep-2011 Administrative Proceeding
Order instituting cease-and-desist proceedings pursuant to Section 21C of the Securities Exchange Act of 1934, making findings, and imposing a cease-and-desist order
On September 1, 2011, the SEC filed an order instituting cease and desist proceedings against Sequenom, Inc. The SEC alleged that the company disclosed "materially misleading scientific data regarding a prenatal screening test for Down syndrome...[b]etween June 2008 and January 2009, Sequenom, office of the company, made several materially misleading statements and omissions to the public through public filings, press release and oral statements." As such, the company violated Section 10(b) and Rule 10b-5, as well as statutory reporting requirements.

Related Actions:

SEC v. Elizabeth A. Dragon